Semaglutide 14mg Tablets: What This Dose Actually Means in the UK

Step 1: Recognise which semaglutide product you are actually looking at

Semaglutide exists as several distinct branded medicines in the UK, each with its own licence and dose range. Rybelsus tablets come in 3mg, 7mg and 14mg. They are prescribed for type 2 diabetes and have no licence for weight management. The 14mg tablet is the highest Rybelsus dose and represents the maintenance level for some people with diabetes who need tighter blood-sugar control.

Wegovy injection, by contrast, is licensed for weight management and uses a different dose ladder entirely: 0.25mg, 0.5mg, 1.0mg, 1.7mg and 2.4mg by injection each week. Then there are Wegovy tablets, approved by the MHRA on 11 June 2026 as the first oral GLP-1 medicine licensed for weight management in the UK. Their schedule runs 1.5mg, 4mg, 9mg and 25mg daily. There is no overlap with Rybelsus doses. This is not a minor technicality. Taking the wrong semaglutide product for the wrong condition is a clinical matter that only a prescriber can navigate safely.

The NHS medicines page for semaglutide on NHS.uk covers both Ozempic and Wegovy, though Rybelsus and Wegovy tablets each have their own prescribing information. If you are reading about biotech semaglutide products online and a 14mg weight-loss dose is mentioned, treat that as a red flag, it does not correspond to any UK-licensed weight-loss product.

Step 2: Understand why the Wegovy tablet doses look so different from injection doses

Swallowing semaglutide creates a significant absorption challenge. The digestive system breaks proteins down efficiently, and semaglutide, being a peptide, would largely be destroyed before reaching the bloodstream at injection-scale doses. Wegovy tablets overcome this by pairing semaglutide with an absorption enhancer called SNAC, which helps the medicine cross the stomach lining. Even so, oral bioavailability is much lower than injection, which is why the tablet doses are measured in milligrams in the double figures at maintenance rather than in fractions of a milligram.

This pharmacology explains why a 25mg Wegovy tablet and a 2.4mg Wegovy injection can both be described as maintenance doses: the numbers are not comparable across routes. It also explains why Rybelsus uses 14mg as a diabetes dose, the delivery mechanism is similar, but the therapeutic target and titration plan are entirely different from the weight-loss programme. Our semaglutide overview page goes into the mechanism in more depth if you would like the full picture.

The practical upshot: if a prescriber moves you from the Wegovy injection to the Wegovy tablet, they do not look at equivalent milligram numbers. People established on the semaglutide 1mg injection dose or higher may move to the tablet form, subject to clinical review. No one should be attempting that switch without prescriber involvement.

Step 3: Know what the licensed weight-loss tablet schedule actually involves

The Wegovy tablet titration begins at 1.5mg daily. You take it first thing in the morning on an empty stomach, with a small amount of plain water (roughly what fits in a teacup) then wait at least 30 minutes before eating, drinking anything else, or taking other oral medicines. Each dose level runs for a minimum of one month before the prescriber considers escalation: 1.5mg, then 4mg, then 9mg, and finally 25mg as the maintenance dose.

One practical advantage over the injection is storage. Wegovy tablets require no refrigeration, which suits people who travel frequently or who find keeping an injectable pen in the fridge door inconvenient. For context on how the tablet compares to the injection in terms of effectiveness, the OASIS 4 trial reported an average weight loss of around 13.6% over 64 weeks, rising to roughly 17% among participants who adhered fully throughout, figures you can explore further on our Wegovy treatment page.

Because the tablet schedule is set by your prescriber based on your clinical picture, no content here can tell you what dose you should be on or when to move up. The Patient Information Leaflet and your prescriber are the right sources for that. If you want to understand what the costs of private treatment look like, the Wegovy cost page covers what is typically included in a private prescription price.

Step 4: Check whether weight-loss semaglutide is the right conversation to start

If your reason for searching semaglutide 14 was curiosity about weight management options, the clinically correct next step is an assessment rather than a dose. Wegovy tablets are licensed for adults with a BMI of 30 or above, or a BMI of 27 to 29.9 alongside at least one weight-related condition such as high blood pressure, raised cholesterol or prediabetes. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. A BMI that meets the licence threshold is a starting point, not a guarantee of suitability, a prescriber reviews your full health picture before any prescription is issued.

At nume, every consultation is personally reviewed by a GPhC-registered Independent Prescriber, not automated software. A real clinician reads your answers the same day. If you are already on a weight-loss medicine elsewhere and wondering whether switching to the tablet is appropriate, that is a question for your current prescriber first. For a broader look at the options available, our weight-loss treatments overview sets out the landscape clearly. When you are ready to discuss your own situation, check your eligibility with our free consultation.